GIACOMO DIAZ

Dr. GIACOMO DIAZ

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2008 in Micron
Verified
Journal Article
Closed access
GDGIACOMO DIAZ
GIACOMO DIAZ
MMMarta Melis
Marta Melis
BBBarbara Batetta
Barbara Batetta
Fabrizio AngiusFabrizio Angius
Fabrizio Angius
AFAngela Maria Falchi
Angela Maria Falchi

12 November 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
ZCZhaochun Chen
Zhaochun Chen
GDGIACOMO DIAZ
GIACOMO DIAZ
TPTeresa Pollicino
Teresa Pollicino
HZHuaying Zhao
Huaying Zhao
RERonald E. Engle
Ronald E. Engle
Patrizia FarciPatrizia Farci
Patrizia Farci
Hepatitis B virus (HBV)-associated acute liver failure (ALF) is a dramatic clinical syndrome leading to death or liver transplantation in 80% of cases. Due to the extremely rapid clinical course, the difficulties in obtaining liver specimens, and the lack of an animal model, the pathogenesis of ALF remains largely unknown. Here, we performed a comprehensive genetic and functional characterization of the virus and the host in liver tissue from HBV-associated ALF and compared the results with those of classic acute hepatitis B in chimpanzees. In contrast with acute hepatitis B, HBV strains detected in ALF livers displayed highly mutated HBV core antigen (HBcAg), associated with increased HBcAg expression ex vivo, which was independent of viral replication levels. Combined gene and miRNA expression profiling revealed a dominant B cell disease signature, with extensive intrahepatic production of IgM and IgG in germline configuration exclusively targeting HBcAg with subnanomolar affinities, and complement deposition. Thus, HBV ALF appears to be an anomalous T cell-independent, HBV core-driven B cell disease, which results from the rare and unfortunate encounter between a host with an unusual B cell response and an infecting virus with a highly mutated core antigen.

21 August 2014 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
MMMarta Melis
Marta Melis
GDGIACOMO DIAZ
GIACOMO DIAZ
DKDavid E Kleiner
David E Kleiner
FZFausto Zamboni
Fausto Zamboni
JKJuraj Kabat
Juraj Kabat
Patrizia FarciPatrizia Farci
Patrizia Farci
The molecular mechanisms whereby hepatitis B virus (HBV) induces hepatocellular carcinoma (HCC) remain elusive. We used genomic and molecular techniques to investigate host-virus interactions by studying multiple areas of the same liver from patients with HCC. We compared the gene signature of whole liver tissue (WLT) versus laser capture-microdissected (LCM) hepatocytes along with the intrahepatic expression of HBV. Gene expression profiling was performed on up to 17 WLT specimens obtained at various distances from the tumor center from individual livers of 11 patients with HCC and on selected LCM samples. HBV markers in liver and serum were determined by real-time polymerase chain reaction (PCR) and confocal immunofluorescence. Analysis of 5 areas of the liver showed a sharp change in gene expression between the immediate perilesional area and tumor periphery that correlated with a significant decrease in the intrahepatic expression of HB surface antigen (HBsAg). The tumor was characterized by a large preponderance of down-regulated genes, mostly involved in the metabolism of lipids and fatty acids, glucose, amino acids and drugs, with down-regulation of pathways involved in the activation of PXR/RXR and PPARα/RXRα nuclear receptors, comprising PGC-1α and FOXO1, two key regulators critically involved not only in the metabolic functions of the liver but also in the life cycle of HBV, acting as essential transcription factors for viral gene expression. These findings were confirmed by gene expression of microdissected hepatocytes. Moreover, LCM of malignant hepatocytes also revealed up-regulation of unique genes associated with cancer and signaling pathways, including two novel HCC-associated cancer testis antigen genes, NUF2 and TTK. Integrated gene expression profiling of whole liver tissue with that of microdissected hepatocytes demonstrated that HBV-associated HCC is characterized by a metabolism switch-off and by a significant reduction in HBsAg. LCM proved to be a critical tool to validate gene signatures associated with HCC and to identify genes that may play a role in hepatocarcinogenesis, opening new perspectives for the discovery of novel diagnostic markers and therapeutic targets.

1 April 1999 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
GDGIACOMO DIAZ
GIACOMO DIAZ
MSMaria Dolores Setzu
Maria Dolores Setzu
AZAndrea Zucca
Andrea Zucca
RIRaffaella Isola
Raffaella Isola
ADAndrea Diana
Andrea Diana
MSM D Setzu
M D Setzu
The subcellular heterogeneity of mitochondrial membrane potential (mΔΨ) was investigated in confluent and sub-confluent cultures of four cell types (human astrocytes, HEp-2, MDCK and Vero cells) in normal growth conditions, hypoxia and apoptosis. The distribution of high-polarized mitochondria, detected by the potential-sensitive probe JC-1, was found to depend on: (1) the proximity to the cell edge; (2) the local absence of cell-cell contacts; and (3) the local absence of acidic vesicles. Both hypoxia and apoptosis produced a general mΔΨ increase with different redistributions of high-polarized mitochondria. Hypoxic cells maintained high-polarized mitochondria for over 24 hours, until cells underwent necrosis. On the other hand, apoptotic cells showed an unexpected convergence of high-polarized mitochondria into an extremely packed mass at one side of the nucleus, in a stage preceding nuclear condensation, but correlated to the retraction of cell-cell contacts.

4 May 2021 in Viruses
Verified
Journal Article
Open access
PDF file
Patrizia FarciPatrizia Farci
Patrizia Farci
GNGrazia Anna Niro
Grazia Anna Niro
FZFausto Zamboni
Fausto Zamboni
GDGIACOMO DIAZ
GIACOMO DIAZ
Hepatitis D virus (HDV) is a small, defective RNA virus that depends on hepatitis B virus (HBV) for virion assembly and transmission. It replicates within the nucleus of hepatocytes and interacts with several cellular proteins. Chronic hepatitis D is a severe and progressive disease, leading to cirrhosis in up to 80% of cases. A high proportion of patients die of liver decompensation or hepatocellular carcinoma (HCC), but the lack of large prospective studies has made it difficult to precisely define the rate of these long-term complications. In particular, the question of whether HDV is an oncogenic virus has been a matter of debate. Studies conducted over the past decade provided evidence that HDV is associated with a significantly higher risk of developing HCC compared to HBV monoinfection. However, the mechanisms whereby HDV promotes liver cancer remain elusive. Recent data have demonstrated that the molecular profile of HCC-HDV is unique and distinct from that of HBV-HCC, with an enrichment of upregulated genes involved in cell-cycle/DNA replication, and DNA damage and repair, which point to genome instability as an important mechanism of HDV hepatocarcinogenesis. These data suggest that HBV and HDV promote carcinogenesis by distinct molecular mechanisms despite the obligatory dependence of HDV on HBV.

12 November 2009 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
APAlessandra Pani
Alessandra Pani
SDSandra Dessì
Sandra Dessì
GDGIACOMO DIAZ
GIACOMO DIAZ
PCPaolo La Colla
Paolo La Colla
CAClaudia Abete
Claudia Abete
FPFrancesco Paoletti
Francesco Paoletti
Intracellular cholesterol metabolism was reported to modulate amyloid-β (Aβ) generation in Alzheimer's disease (AD). Results presented herein demonstrated that, like brain cells, cultured skin fibroblasts from AD patients contained more cholesterol e